Quality of diagnostic staging in patients with bladder cancer: A process-outcomes link-Reference-Cited by-同舟云学术

Quality of diagnostic staging in patients with bladder cancer: A process-outcomes link

Published:2014-10-22 Issue:3 Volume:121 Page:379-385
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Chamie Karim¹²,Ballon-Landa Eric³⁴,Bassett Jeffrey C.¹²,Daskivich Timothy J.¹²,Leventhal Meryl⁵,Deapen Dennis⁵,Litwin Mark S.¹²⁶

Affiliation:

1. Department of Urology; David Geffen School of Medicine, University of California Los Angeles; Los Angeles California

2. Jonsson Comprehensive Cancer Center; David Geffen School of Medicine, University of California Los Angeles; Los Angeles California

3. University of California Irvine School of Medicine; Irvine California

4. Department of Community Health Sciences; Fielding School of Public Health, University of California Los Angeles; Los Angeles California

5. Cancer Surveillance Program, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California; Los Angeles California

6. Department of Health Policy and Management; Fielding School of Public Health, University of California Los Angeles; Los Angeles California

Funder

National Institutes of Health

STOP Cancer Research Career Development Award

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29071/fullpdf

Reference20 articles.

1. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013;Babjuk;Eur Urol,2013

2. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update;Hall;J Urol,2007

3. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis;Gore;Cancer,2009

4. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma;Sanchez-Ortiz;J Urol,2003

5. Immediate radical cystectomy vs conservative management for high grade cT1 bladder cancer: is there a survival difference?;Badalato;BJU Int,2012

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose-Escalated Radiation Therapy as Primary Treatment for Residual Bladder Cancer After Transurethral Resection;Advances in Radiation Oncology;2024-01

2. MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate Staging of Muscle-Invasive Bladder Cancer;International Journal of Molecular Sciences;2023-12-20

3. A Procedural Checklist for Transurethral Resection of Bladder Tumors (TURBT) Enhances Operative Dictation and Assesses Surgeon Accuracy of Tumor Characteristic Predictions;Bladder Cancer;2023-12-13

4. Tislelizumab with gemcitabine and cisplatin as a neoadjuvant regimen for muscle-invasive bladder cancer: case series;Annals of Medicine & Surgery;2023-11-20

5. Audit, Feedback, and Education to Improve Quality and Outcomes in Transurethral Resection and Single-Instillation Intravesical Chemotherapy for Nonmuscle Invasive Bladder Cancer Treatment: Protocol for a Multicenter International Observational Study With an Embedded Cluster Randomized Trial;JMIR Research Protocols;2023-06-15